These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38281454)

  • 1. Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis.
    Wu KY; Cheong IS; Lai JN; Hu CY; Hung KC; Chen YT; Chiu LT; Tsai HT; Jou YC; Tzai TS; Tsai YS
    Cancer Epidemiol; 2024 Apr; 89():102536. PubMed ID: 38281454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
    Kates M; Badalato GM; Gupta M; McKiernan JM
    BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.
    Miest T; Khanna A; Sharma V; Hensley PJ; Campbell R; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Potretzke A; Matin SF; Murthy PB; Haber GP; Lee B; Boorjian SA
    J Urol; 2022 Feb; 207(2):284-292. PubMed ID: 34547921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
    Wu K; Liu X; Wang Y; Wang X; Li X
    Front Public Health; 2022; 10():994351. PubMed ID: 36388369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients.
    Hsiao PJ; Hsieh PF; Chang CH; Wu HC; Yang CR; Huang CP
    Ren Fail; 2016 Jun; 38(5):663-70. PubMed ID: 26956094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease is Associated With Upper Tract Urothelial Carcinoma: A Nationwide Population-Based Cohort Study in Taiwan.
    Chen JS; Lu CL; Huang LC; Shen CH; Chen SC
    Medicine (Baltimore); 2016 Apr; 95(14):e3255. PubMed ID: 27057873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of previous malignancy at diagnosis on oncological outcomes of upper tract urothelial carcinoma.
    Zhao H; Liu K; Giannakopoulos S; Yuruk E; De Naeyer G; Álvarez-Maestro M; Ng CF; Laguna P; De La Rosette J; Yuen-Chun Teoh J
    BMC Urol; 2023 Mar; 23(1):49. PubMed ID: 36991375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latency period of aristolochic acid-induced upper urinary tract urothelial carcinoma.
    Jhuang JR; Chiu PC; Hsieh TC; Chen CH; Pu YS; Lee WC
    Front Public Health; 2023; 11():1072864. PubMed ID: 36969664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram for overall survival of second primary cancers following upper-tract urothelial carcinoma: a SEER population-based study.
    Zhang X; Chen W; Li C; Wan X; Xu P; Zhang T
    Transl Cancer Res; 2024 Aug; 13(8):4131-4145. PubMed ID: 39262482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender effect on the oncologic outcomes of upper urinary tract urothelial carcinoma in Taiwan.
    Wu YT; Luo HL; Wang HJ; Chen YT; Cheng YT; Chiang PH
    Int Urol Nephrol; 2020 Jun; 52(6):1043-1048. PubMed ID: 31997062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
    Teng CJ; Huon LK; Hu YW; Yeh CM; Chao Y; Yang MH; Chen TJ; Hung YP; Liu CJ
    Medicine (Baltimore); 2015 Oct; 94(43):e1803. PubMed ID: 26512575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.
    Chen SC; Liu CJ; Hu YW; Yeh CM; Hu LY; Wang YP; Hung YP; Tzeng CH; Chiou TJ; Chen TJ; Teng CJ
    Gastric Cancer; 2016 Apr; 19(2):490-497. PubMed ID: 25772342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis.
    Wright JL; Hotaling J; Porter MP
    J Urol; 2009 Mar; 181(3):1035-9; discussion 1039. PubMed ID: 19150569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin therapy and upper tract urothelial carcinoma risk in hyperlipidemic patients with chronic kidney disease and end-stage kidney disease, a population-based 17-year follow-up study.
    Cheng YC; Sung FC; Muo CH; Hsu CC; Tsai WC; Hsu YH
    Ren Fail; 2024 Dec; 46(2):2402508. PubMed ID: 39301874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
    D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
    BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Genomic Profiling of Upper-tract and Bladder Urothelial Carcinoma.
    Necchi A; Madison R; Pal SK; Ross JS; Agarwal N; Sonpavde G; Joshi M; Yin M; Miller VA; Grivas P; Chung JH; Ali SM
    Eur Urol Focus; 2021 Nov; 7(6):1339-1346. PubMed ID: 32861617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
    van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
    Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.